United States
Premiumsupplier
Ofatumumab CAS NO.679818-59-8
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- Ofatumumab
Quick Details
- ProName: Ofatumumab
- CasNo: 679818-59-8
- Molecular Formula: C6480H10022N1742O2020S44
- Application: the treatment of chronic lymphocytic l...
- Purity: 95%
- LimitNum: 0
Superiority
We provide customized and high-quality Ofatumumab product for your project.
Details
Ofatumumab is a CD20-directed cytolytic monoclonal antibody with an inhibitory effect on early-stage B lymphocyte. It was approved by FDA for its use to treat patients with chronic lymphocytic leukemia (CLL) as an extended treatment or in combination with chlorambucil. It also has the thearapeutic effect on some other diseases such as follicular lymphoma.
